Company Overview and News

3
Indiabulls Housing Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

16h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Updates

2018-06-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance raises Rs 2,318 cr via bonds

2018-06-15 moneycontrol
Indiabulls Housing Finance has raised Rs 2,318.50 crore by issuing bonds on a private placement basis. This is part of the company's Rs 24,000 crore fund raise plan. Indiabulls Housing Finance had announced to raise Rs 24,000 crore by way of issuance of secure, redeemable, non-convertible debentures on private placement basis in December 2017.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Updates

2018-06-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

12
Market Update: Nifty pharma continues to rally as Dr Reddy#39;s jumps 3%; RIL hits record high

2018-06-15 moneycontrol
The broader indices are trading on a flat to positive note this Friday morning with the Nifty up 19 points at 10,822 and the Sensex is up 47 points at 35,647.
500325 UBL RELIANCE IDKQY UBHOLDINGS TCHQY TTNQY 532755 UNBWY 532478 TECHM 535789 IBULHSGFIN 532540 BAJFINANCE INOXWIND RIGD BJJQY TCS 507458 539083 500034 RLNIY

47
Forbes list: 5th biggest consumer financial services company

2018-06-14 freepressjournal.in
New York : Housing finance major HDFC has been ranked as the fifth biggest public company globally in the ‘consumer financial services category’ on a list compiled by Forbes magazine. American Express has topped this category, while Indiabulls Housing Finance is the only other Indian company (at 13th place) on the list. In the consumer financial services category, HDFC’s rank has moved up from 7th place last year.
COF.PRG COF.PRH DFS COF-P 500325 RELIANCE COF.WS IDKQY COF.PRP COF SYF COF-D DFS.PRB DFS.PRBCL 535789 IBULHSGFIN COF-C COF-F RIGD COF.PRC COF.PRD COF.PRF RLNIY

15
Market Update: Nifty pharma outperforms led by Aurobindo Pharma; PSU banks drag

2018-06-14 moneycontrol
The broader indices are trading on a negative note this Thursday afternoon with the Nifty shedding 67 points at 10,789 and the Sensex is down 200 points at 35,539.
GRASIM 500325 AUROPHARMA RELIANCE TCHQY 532755 511389 VIDEOIND TTNQY 535789 532540 532461 532483 RIGD HDFCBANK GAILF TV18BRDCST RLNIY SBAZ UBNC GRSJY JAGRAN 524804 IDKQY 532705 532800 TECHM CNRYY IBULHSGFIN GRSXY PNJZY HDB 500180 ARBQY GAILY 500300 TCS PNB CANBK

3
Indiabulls Housing Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Record Date

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Record Date

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Updates

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

3
Indiabulls Housing Finance Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
535789 IBULHSGFIN IDKQY

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

7h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

8h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...